SCHEMBL8892322

SCHEMBL8892322

Nc1cc(Br)cnc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041615 0.75 — —
SCHEMBL15618232 0.75 HTT (0.52) —
SCHEMBL29636055 0.75 — —
SCHEMBL189764 0.75 — —
SCHEMBL14421716 0.75 — —
SCHEMBL202631 0.75 — —
SCHEMBL618186 0.71 — —
SCHEMBL21317737 0.71 — —
SCHEMBL858870 0.71 — —
SCHEMBL13180224 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140527-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. (US) 2022-06-30 — — WO disclosed
CN-108473476-B Alkynyl heterocyclic compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2021-02-19 — — CN disclosed
CN-108473476-A Alkynyl heterocyclic compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2018-08-31 — — CN disclosed
WO-1997043292-A1 NEW THIAZOLOPYRIDINES KLINGE PHARMA GMBH (DE) 1997-11-20 — — WO disclosed
Send feedback